358 A Multi-arm Phase 1 Dose Escalation Study of Safety, Pharmacokinetics, and Pharmacodynamics of the Dual PI3K/mTOR Inhibitors PF-04691502 (oral) and PF-05212384 (IV) in Combination with the MEK Inhibitor PD-0325901 or Irinotecan in Patients with Advanced Cancer

✍ Scribed by Britten, C.; Wainberg, Z.; Tabernero, J.; Alsina Maqueda, M.; Leong, S.; Sessa, C.; Millham, R.; Gallo, J.; Siu, L.; Brana, I.

• Book ID: 123422436
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 55 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(12)72156-1